CA Stock MarketDetailed Quotes

Microbix Biosystems Inc (MBX)

Watchlist
  • 0.230
  • -0.025-9.80%
15min DelayMarket Closed May 14 16:00 ET
31.87MMarket Cap-7.67P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Microbix Biosystems Inc (MBX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-428.30%-2.6M
-101.85%-80.29K
-89.04%83.95K
-237.06%-1.92M
15.19%966.75K
-40.80%792.7K
497.20%4.35M
152.60%765.93K
-34.15%1.4M
179.48%839.25K
Net income from continuing operations
-236.20%-1.17M
-163.80%-2.25M
-436.27%-1.48M
-765.78%-1.64M
-94.53%20.66K
-65.10%856.96K
9,015.68%3.52M
-77.95%440.32K
132.08%246.75K
1,094.74%377.73K
Operating gains losses
----
----
----
----
----
----
---166.63K
--0
---166.63K
----
Depreciation and amortization
4.91%456.29K
10.33%1.78M
18.01%471.53K
4.26%444.85K
5.91%428.04K
13.73%434.94K
39.38%1.61M
29.22%399.57K
40.25%426.66K
33.64%404.15K
Asset impairment expenditure
----
----
----
----
----
----
--0
----
----
----
Remuneration paid in stock
-9.52%160.53K
-8.97%650.19K
12.07%160.53K
-11.74%160.53K
-20.53%151.71K
-10.50%177.43K
-2.86%714.29K
-16.89%143.25K
-10.15%181.89K
2.89%190.9K
Other non cashItems
35.53%160.97K
12.14%494.55K
3.04%116.99K
21.30%134.36K
12.50%124.43K
11.92%118.77K
25.70%441.03K
12.15%113.54K
16.29%110.77K
39.26%110.6K
Change In working capital
-178.23%-2.21M
57.24%-758.58K
346.58%815.57K
-268.97%-1.02M
199.08%241.91K
55.89%-795.4K
-706.98%-1.77M
65.46%-330.75K
-73.72%604.06K
85.25%-244.14K
-Change in receivables
-212.89%-2.37M
20,385.11%2.58M
755.23%784.23K
-69.92%118.77K
505.07%2.43M
---758.69K
98.83%-12.71K
---119.69K
--394.84K
-107.64%-600.87K
-Change in inventory
81.04%-115.89K
-283.39%-2.73M
-55.86%-334.99K
-535.85%-585.18K
-9,172.16%-1.2M
---611.19K
-52.51%-712.38K
---214.93K
---92.03K
98.31%-12.94K
-Change in prepaid assets
-60.48%8.03K
-110.14%-12.57K
-37.79%91.3K
-132.45%-129.33K
101.86%5.16K
--20.31K
189.02%123.98K
--146.76K
--398.51K
-354.56%-277.77K
-Change in payables and accrued expense
-942.37%-324.9K
-275.69%-685.06K
-37.25%381.2K
-217.57%-347.06K
-1,174.80%-757.76K
--38.57K
55.26%389.92K
--607.51K
--295.19K
138.49%70.5K
-Change in other working capital
15.13%593.64K
105.89%91.99K
85.85%-106.16K
80.16%-77.86K
-141.53%-239.59K
--515.6K
-227.85%-1.56M
---750.41K
---392.45K
209.96%576.94K
Cash from discontinued investing activities
Operating cash flow
-428.30%-2.6M
-101.85%-80.29K
-89.04%83.95K
-237.06%-1.92M
15.19%966.75K
-40.80%792.7K
497.20%4.35M
152.60%765.93K
-34.15%1.4M
179.48%839.25K
Investing cash flow
Cash flow from continuing investing activities
16.10%-170.37K
58.19%-797.3K
32.76%-154.31K
80.59%-194.65K
61.55%-245.29K
-453.28%-203.05K
-87.63%-1.91M
-94.72%-229.49K
-366.10%-1M
-15.75%-637.91K
Net PPE purchase and sale
16.10%-170.37K
51.27%-797.3K
32.76%-154.31K
73.41%-194.65K
61.55%-245.29K
-453.28%-203.05K
-61.00%-1.64M
-94.72%-229.49K
-240.31%-732.05K
-15.75%-637.91K
Net intangibles purchas and sale
----
--0
--0
--0
----
----
---270.6K
--0
---270.6K
----
Cash from discontinued investing activities
Investing cash flow
16.10%-170.37K
58.19%-797.3K
32.76%-154.31K
80.59%-194.65K
61.55%-245.29K
-453.28%-203.05K
-87.63%-1.91M
-94.72%-229.49K
-366.10%-1M
-15.75%-637.91K
Financing cash flow
Cash flow from continuing financing activities
51.99%-242.41K
102.49%27K
121.53%82.21K
31.30%-319.53K
792.37%769.27K
-301.12%-504.95K
-572.95%-1.08M
-67.04%-381.88K
-103.39%-465.14K
-112.30%-111.11K
Net issuance payments of debt
6.17%-68.69K
-171.39%-1.42M
6.32%-68.69K
82.53%-52.86K
-1,568.22%-1.22M
0.16%-73.21K
-142.16%-522.49K
-82.44%-73.33K
-312.18%-302.51K
-106.03%-73.33K
Net common stock issuance
66.02%-173.72K
-87.03%-1.73M
33.86%-208.35K
-63.97%-266.68K
-88.38%-744.27K
-872.81%-511.29K
17.03%-925.28K
-67.18%-315.01K
2.06%-162.63K
1.26%-395.08K
Proceeds from stock option exercised by employees
--0
674.25%2.82M
--0
--0
665.96%2.74M
--79.55K
245.57%363.75K
--6.45K
--0
310.93%357.3K
Net other financing activities
----
--359.25K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
51.99%-242.41K
102.49%27K
121.53%82.21K
31.30%-319.53K
792.37%769.27K
-301.12%-504.95K
-572.95%-1.08M
-67.04%-381.89K
-103.39%-465.14K
-112.30%-111.11K
Net cash flow
Beginning cash position
-6.56%12.11M
11.69%12.96M
-5.53%12.1M
12.94%14.54M
2.07%13.05M
11.69%12.96M
-13.95%11.61M
-4.48%12.81M
9.82%12.87M
2.88%12.78M
Current changes in cash
-3,659.71%-3.02M
-162.69%-850.58K
-92.33%11.86K
-3,691.06%-2.44M
1,552.11%1.49M
-92.80%84.7K
172.11%1.36M
108.57%154.56K
-103.81%-64.31K
112.82%90.23K
End cash Position
-30.28%9.1M
-6.56%12.11M
-6.56%12.11M
-5.53%12.1M
12.94%14.54M
2.07%13.05M
11.69%12.96M
11.69%12.96M
-4.48%12.81M
9.82%12.87M
Free cash from
-570.24%-2.77M
-135.95%-877.58K
-113.11%-70.35K
-628.48%-2.12M
258.33%721.46K
-54.72%589.65K
215.64%2.44M
134.08%536.44K
-79.08%400.84K
112.53%201.34K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -428.30%-2.6M-101.85%-80.29K-89.04%83.95K-237.06%-1.92M15.19%966.75K-40.80%792.7K497.20%4.35M152.60%765.93K-34.15%1.4M179.48%839.25K
Net income from continuing operations -236.20%-1.17M-163.80%-2.25M-436.27%-1.48M-765.78%-1.64M-94.53%20.66K-65.10%856.96K9,015.68%3.52M-77.95%440.32K132.08%246.75K1,094.74%377.73K
Operating gains losses ---------------------------166.63K--0---166.63K----
Depreciation and amortization 4.91%456.29K10.33%1.78M18.01%471.53K4.26%444.85K5.91%428.04K13.73%434.94K39.38%1.61M29.22%399.57K40.25%426.66K33.64%404.15K
Asset impairment expenditure --------------------------0------------
Remuneration paid in stock -9.52%160.53K-8.97%650.19K12.07%160.53K-11.74%160.53K-20.53%151.71K-10.50%177.43K-2.86%714.29K-16.89%143.25K-10.15%181.89K2.89%190.9K
Other non cashItems 35.53%160.97K12.14%494.55K3.04%116.99K21.30%134.36K12.50%124.43K11.92%118.77K25.70%441.03K12.15%113.54K16.29%110.77K39.26%110.6K
Change In working capital -178.23%-2.21M57.24%-758.58K346.58%815.57K-268.97%-1.02M199.08%241.91K55.89%-795.4K-706.98%-1.77M65.46%-330.75K-73.72%604.06K85.25%-244.14K
-Change in receivables -212.89%-2.37M20,385.11%2.58M755.23%784.23K-69.92%118.77K505.07%2.43M---758.69K98.83%-12.71K---119.69K--394.84K-107.64%-600.87K
-Change in inventory 81.04%-115.89K-283.39%-2.73M-55.86%-334.99K-535.85%-585.18K-9,172.16%-1.2M---611.19K-52.51%-712.38K---214.93K---92.03K98.31%-12.94K
-Change in prepaid assets -60.48%8.03K-110.14%-12.57K-37.79%91.3K-132.45%-129.33K101.86%5.16K--20.31K189.02%123.98K--146.76K--398.51K-354.56%-277.77K
-Change in payables and accrued expense -942.37%-324.9K-275.69%-685.06K-37.25%381.2K-217.57%-347.06K-1,174.80%-757.76K--38.57K55.26%389.92K--607.51K--295.19K138.49%70.5K
-Change in other working capital 15.13%593.64K105.89%91.99K85.85%-106.16K80.16%-77.86K-141.53%-239.59K--515.6K-227.85%-1.56M---750.41K---392.45K209.96%576.94K
Cash from discontinued investing activities
Operating cash flow -428.30%-2.6M-101.85%-80.29K-89.04%83.95K-237.06%-1.92M15.19%966.75K-40.80%792.7K497.20%4.35M152.60%765.93K-34.15%1.4M179.48%839.25K
Investing cash flow
Cash flow from continuing investing activities 16.10%-170.37K58.19%-797.3K32.76%-154.31K80.59%-194.65K61.55%-245.29K-453.28%-203.05K-87.63%-1.91M-94.72%-229.49K-366.10%-1M-15.75%-637.91K
Net PPE purchase and sale 16.10%-170.37K51.27%-797.3K32.76%-154.31K73.41%-194.65K61.55%-245.29K-453.28%-203.05K-61.00%-1.64M-94.72%-229.49K-240.31%-732.05K-15.75%-637.91K
Net intangibles purchas and sale ------0--0--0-----------270.6K--0---270.6K----
Cash from discontinued investing activities
Investing cash flow 16.10%-170.37K58.19%-797.3K32.76%-154.31K80.59%-194.65K61.55%-245.29K-453.28%-203.05K-87.63%-1.91M-94.72%-229.49K-366.10%-1M-15.75%-637.91K
Financing cash flow
Cash flow from continuing financing activities 51.99%-242.41K102.49%27K121.53%82.21K31.30%-319.53K792.37%769.27K-301.12%-504.95K-572.95%-1.08M-67.04%-381.88K-103.39%-465.14K-112.30%-111.11K
Net issuance payments of debt 6.17%-68.69K-171.39%-1.42M6.32%-68.69K82.53%-52.86K-1,568.22%-1.22M0.16%-73.21K-142.16%-522.49K-82.44%-73.33K-312.18%-302.51K-106.03%-73.33K
Net common stock issuance 66.02%-173.72K-87.03%-1.73M33.86%-208.35K-63.97%-266.68K-88.38%-744.27K-872.81%-511.29K17.03%-925.28K-67.18%-315.01K2.06%-162.63K1.26%-395.08K
Proceeds from stock option exercised by employees --0674.25%2.82M--0--0665.96%2.74M--79.55K245.57%363.75K--6.45K--0310.93%357.3K
Net other financing activities ------359.25K--------------------------------
Cash from discontinued financing activities
Financing cash flow 51.99%-242.41K102.49%27K121.53%82.21K31.30%-319.53K792.37%769.27K-301.12%-504.95K-572.95%-1.08M-67.04%-381.89K-103.39%-465.14K-112.30%-111.11K
Net cash flow
Beginning cash position -6.56%12.11M11.69%12.96M-5.53%12.1M12.94%14.54M2.07%13.05M11.69%12.96M-13.95%11.61M-4.48%12.81M9.82%12.87M2.88%12.78M
Current changes in cash -3,659.71%-3.02M-162.69%-850.58K-92.33%11.86K-3,691.06%-2.44M1,552.11%1.49M-92.80%84.7K172.11%1.36M108.57%154.56K-103.81%-64.31K112.82%90.23K
End cash Position -30.28%9.1M-6.56%12.11M-6.56%12.11M-5.53%12.1M12.94%14.54M2.07%13.05M11.69%12.96M11.69%12.96M-4.48%12.81M9.82%12.87M
Free cash from -570.24%-2.77M-135.95%-877.58K-113.11%-70.35K-628.48%-2.12M258.33%721.46K-54.72%589.65K215.64%2.44M134.08%536.44K-79.08%400.84K112.53%201.34K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 +2.01%
Sample Name
Sample Code
 +0.78%
4
SINOPEC CORP
00386
-1.09%
5
CNOOC
00883
-1.57%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.80%
Sample Name
Sample Code
 +38.34%
Sample Name
Sample Code
 +27.56%
4
Digital China Group
000034
+16.93%
5
Loongson Technology Corporation
688047
+16.65%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -